Champions Oncology is a biotechnology company that provides personalized medicine solutions for cancer patients. The company was founded in 2007 by Ronnie Morris and David Sidransky. Champions Oncology's products and services include patient-derived xenograft (PDX) models, which are used to test the efficacy of cancer drugs; TumorGrafts, which are used to predict patient response to cancer treatments; and biomarker discovery services, which are used to identify new cancer drug targets. Champions Oncology has partnerships with pharmaceutical companies, academic institutions, and cancer centers around the world. The company is headquartered in Baltimore, Maryland.